Developing story · 2 episodes · 16 Sept to 17 Sept
AI Agents Transform Research and Drug Discovery
The series follows the emergence of AI systems that turn scientific papers into autonomous agents and apply AI to biotech drug discovery. The latest developments show AI agents now not only interpret research but also predict clinical trial outcomes, signaling a move toward AI-driven drug development.
-
Virtual Biotech AI system could predict trial success and identify lung‑cancer drug candidate, study says
A team led by Stanford computer scientist James Zou built a massive AI platform called Virtual Biotech, composed of up to 37,000 autonomous agents that interact with large language models. Using…
1 source primary source -
Stanford's Paper2Agent turns research papers into executable AI agents
Stanford researchers led by Jiacheng Miao and James Zou have released Paper2Agent, a system published in Nature that automates the conversion of computational research papers and their codebases…
2 sources primary source
Who and what